Clinical Trial Update: Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance [Phase 1]

View source ↗

Summary

Phase 1 clinical trial investigating whether human mesenchymal stem cells can induce tolerance in liver transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Human Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Evidence of Liver Transplantation | Phase 1 | Status: UNKNOWN